Enhancing the Use of Integrated Continuous Glucose Monitoring Devices: Highlighting the Roles of the Pharmacist and Pharmacy Technician (Pharmacy Technician Credit)

This activity is part 3 of a 3-part webinar curriculum.

This activity includes patient counseling video vignettes and an iCGM device demonstration.  

Program Description

Pharmacists are frequently involved in the therapeutic management of chronic disease states, including type 1 and type 2 diabetes. Pharmacists and pharmacy technicians can help raise awareness of the potential benefits of integrated continuous glucose monitoring (iCGM) devices, assist with access, and optimize the use of this technology. The data from iCGM devices provide patients with diabetes with a glimpse of their glucose levels over a typical day, enabling health care providers and patients to identify possible issues that may necessitate modifications in their treatment plan or daily habits. Pharmacists can play an instrumental role in helping patients with diabetes understand their iCGM device and the information it provides by counseling them on how to apply the device, providing education on different features, and reviewing the information from the iCGM device. Included in this activity are counseling and device demonstration videos that offer important educational pearls to assist patients with diabetes with the appropriate use of iCGM devices.

Target audience: Retail pharmacists, health-system pharmacists, and pharmacy technicians

Type of activity: Application for pharmacists; knowledge for pharmacy technicians
Release date: May 16, 2022
Expiration date: May 16, 2023

Time to complete activity: 1.0 hour
Fee: Free

Educational Objectives

Pharmacy Technician Educational Objectives
At the completion of this activity, participants will be able to:

• Discuss the role of the pharmacy technician in assisting patients with diabetes that are candidates for or currently using integrated continuous glucose monitoring (iCGM) devices
• Indicate best practices that pharmacy technicians should be aware of to encourage optimal use of iCGM devices
• List common barriers to implementation and use of iCGM

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.0 contact hour (0.10 CEU) under the ACPE universal activity numbers 0290-0000-22-259-H01-P and 0290-0000-22-260-H01-T. The activity is available for CE credit through May 16, 2023.

Instructions for Completing the Activity and Receiving CPE Credit

To receive CPE credit, participants must complete the pretest, view the webinar in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.

Disclosures

Faculty

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP, has the following relevant financial relationships with commercial interests to disclose:
Grant/Research Support: Dexcom
Consultant: Klinio, Undermyfork, Tempramed
Speakers Bureau: Abbott, Dexcom, Medtronic, Insulet, Bayer, Novo Nordisk

Pharmacy Times Continuing Education™ Planning Staff—Jim Palatine, RPh, MBA; Maryjo Dixon, RPh; Liza Patel, PharmD, RPh; Karleen Melody, PharmD; Crissy Wilson; Susan Pordon; Brianna Winters; and Chloe Taccetta have no relevant financial relationships with commercial interests to disclose.

Anonymous peer reviewers were used as part of content validation and conflict resolution. The peer reviewers have no relevant financial relationships with commercial interests to disclose.

Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.

For questions about this internet CPE activity, please contact:
[email protected]
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms